VetStem, Inc. Completes FDA-Review for Second Allogeneic Off-the-Shelf Cell Medicine Product in the U.S.
VetStem, Inc. announces PrecisePRP™ Equine has cleared the FDA review process and is launching in May 2024 in the U.S. POWAY, CALIFORNIA, U.S., May 8, 2024 /EINPresswire.com/ -- Last month, leading regenerative veterinary medicine company, …